| Last Price | 11.00 | Max Price | 11.00 |
| Min Price | 2.44 | 1 Year return | -29.94 |
| Avg. Target | 0.00 | Expected Return | - |
| Sector | Health Care | Subsector | Pharmaceuticals |
| Sell | 0 | Rating | |
| Hold | 0 | Concensus | |
| Buy | 0 |
Contact info:Country: Germany
| Year | Turnover | Total sector | Market share |
|---|---|---|---|
| 2019 | 31 | 474,848 | 0.01 % |
| 2020 | 30 | 469,560 | 0.01 % |
| 2021 | 29 | 566,739 | 0.01 % |
| 2022 | 26 | 640,095 | 0.00 % |
| 2023 | 32 | 590,728 | 0.01 % |
No Records Found
No Records Found
No Records Found
No Records Found
| Results |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Revenue |
|
|
|
|
|
| Costs |
|
|
|
|
|
| Profit |
|
|
|
|
|
| Margin of profit |
|
|
|
|
|
| ROI |
|
|
|
|
|
| Balance |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Equity |
|
|
|
|
|
| Debt |
|
|
|
|
|
| Total assets |
|
|
|
|
|
| Solvency |
|
|
|
|
|
| Cash |
|
|
|
|
|
| Cashflow |
|
|
|
|
|
| Employees |
|
|
|
|
|
| Revenue per employee |
|
|
|
|
|
| Cashflow / Debt |
|
|
|
|
|
| Details |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Price |
35.11
|
46.14
|
58.46
|
53.68
|
35.59
|
| Eps |
-3.77
|
-4.45
|
-2.37
|
-1.92
|
-2.80
|
| Price/earnings-ratio |
-9.31
|
-10.37
|
-24.67
|
-27.96
|
-3.93
|
| Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
| Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Book value |
4.67
|
0.89
|
4.28
|
2.59
|
1.80
|
| Market to book |
0.13
|
0.02
|
0.07
|
0.05
|
0.16
|
| Cashflow per stock |
-3.17
|
-3.45
|
-3.51
|
-8.56
|
-0.70
|
| Stocks |
3
|
4
|
4
|
4
|
4
|
| Market Cap |
119.14
|
175.62
|
223.60
|
206.31
|
45.01
|
|
Date
|
Price
|
|---|---|
|
01 May 2026
|
11.00
|
|
28 Apr 2026
|
11.00
|
|
21 Apr 2026
|
11.00
|
|
14 Apr 2026
|
11.00
|
|
28 Jan 2026
|
11.00
|
|
21 Dec 2025
|
2.44
|